NEW APPROACHES IN THE TREATMENT AND PREVENTION OF RECURRENT OBSTRUCTIVE BRONCHITIS

Authors

  • Khaydarov Odilkhon Lazizovich Student of Group 508, Faculty of Medicine No. 1, Samarkand State Medical University, Samarkand, Uzbekistan
  • Lim Maxim Vyacheslavovich Scientific supervisor: PhD., Associate Professor

Keywords:

beclomethasone, E:I index, recurrent obstructive bronchitis, children.

Abstract

In a study of children with recurrent obstructive bronchitis, the effectiveness of inhaled beclamethasone was established. 54 patients with recurrent obstructive bronchitis were examined. The study showed that patients receiving inhaled beclomethasone experienced statistically significant positive dynamics in clinical symptoms, improvement in E:I index starting from the 3rd day of treatment by an average of 0.24-0.37 (P<0.05; P <0.01) until the last days of observation in comparison with patients treated according to standard protocols. Inhaled use of beclamethasone at a dose of 100 mcg/day led to a significant decrease (2.4-3.6 times) in the incidence of relapses in patients with obstructive bronchitis within 12 months after taking the drug.

References

Shavazi N.M., Gaibullaev Zh. Sh., Lim M.V., Ruzikulov B.Sh., Kardzhavova G.A., Allanazarov A.B., Ibragimova M.F. Inhalation of acetylcysteine in the treatment of recurrent obstructive bronchitis in children // Questions of science and education. 2020. No. 29 (113).

Shavazi N.M., Lim M.V., and Karimova G.M. "The state of cardiac hemodynamics according to an echocardiographic study in young children with pneumonia complicated by infectious-toxic shock" Bulletin of Emergency Medicine, No. 3, 2013, pp. 289-290.

Downloads

Published

2024-05-18

Issue

Section

Articles

How to Cite

NEW APPROACHES IN THE TREATMENT AND PREVENTION OF RECURRENT OBSTRUCTIVE BRONCHITIS. (2024). Proceedings of International Conference on Modern Science and Scientific Studies, 3(5), 174-181. https://econferenceseries.com/index.php/icmsss/article/view/4751